Novel Fluticasone Propionate and Salmeterol Fixed-Dose Combination Nano-Encapsulated Particles Using Polyamide Based on L-Lysine
One of the key challenges in developing a dry powder inhaler (DPI) of an inhalable potent fixed-dose combination (FDC) is the ability of the formulation to generate an effective and reproducible aerosol able to reach the lower parts of the lungs. Herein, a one-step approach is presented to expedite...
Saved in:
Main Authors: | Mohammad H. Alyami (Author), Eman Zmaily Dahmash (Author), Dalia Khalil Ali (Author), Hamad S. Alyami (Author), Hussien AbdulKarim (Author), Samar A. Alsudir (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Improvement of airflow limitation by fluticasone propionate/salmeterol in chronic obstructive pulmonary disease: what is the specific marker?
by: Keiichiro eAkamatsu, et al.
Published: (2011) -
New developed spectrophotometric method for simultaneous determination of salmeterol xinafoate and fluticasone propionate in bulk powder and Seritide® diskus inhalation
by: Ahmed Samir, et al.
Published: (2012) -
Development of orally dissolving films for pediatric-centric administration of anti-epileptic drug topiramate - A design of experiments (DoE) study
by: Eman Zmaily Dahmash, et al.
Published: (2021) -
Treatment adherence and level of control in moderate persistent asthma in children and adolescents treated with fluticasone and salmeterol
by: Nulma S. Jentzsch, et al.
Published: (2019) -
Treatment adherence and level of control in moderate persistent asthma in children and adolescents treated with fluticasone and salmeterol
by: Nulma S. Jentzsch, et al.
Published: (2019)